Baseline HBV DNA Level Is the Most Important Factor Associated With Virologic Breakthrough in Chronic Hepatitis B Treated With Lamivudine

World Journal of Gastroenterology - China
doi 10.3748/wjg.v13.i30.4085
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Baishideng Publishing Group Inc.

Related search

The Effect of Prophylactic Lamivudine Plus Adefovir Therapy Compared With Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients With High Baseline HBV DNA During Chemotherapy

PLoS ONE
Multidisciplinary
2016English

Pretreatment Serum HBsAg-to-HBV DNA Ratio Predicts a Virologic Response to Entecavir in Chronic Hepatitis B

The Korean Journal of Hepatology
2011English

Associations Between HBeAg Status, HBV DNA, ALT Level and Liver Histopathology in Patients With Chronic Hepatitis B

Science Journal of Clinical Medicine
2014English

Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil

Gut
Gastroenterology
2006English

HBV DNA Suppression and HBsAg Clearance in HBeAg Negative Chronic Hepatitis B Patients on Lamivudine Therapy for Over 5years

Journal of Hepatology
Hepatology
2012English

Antiviral Therapy Against Chronic Hepatitis B in Brazil: High Rates of Lamivudine Resistance Mutations and Correlation With HBV Genotypes

Memorias do Instituto Oswaldo Cruz
MedicineMicrobiology
2012English

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

Jundishapur Journal of Microbiology
Infectious DiseasesMicrobiology
2014English

HBV Associated Nephrotic Syndrome: Resolution With Oral Lamivudine

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection

Farmeconomia. Health economics and therapeutic pathways
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy